UPDATE : Friday, September 20, 2019
Market value of biopharmaceuticals drops ₩10 trillion on 'Black Monday' by Lee Han-soo 2019-08-06 13:50
Crystal Genomics confirms efficacy of inflammatory bowel disease treatment by Lee Han-soo 2019-08-05 17:02
Boycott of Japanese drug intensifies as Seoul-Tokyo relations worsen by Lee Han-soo 2019-08-05 16:01
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales by Kim Yun-mi 2019-08-05 15:37
Helixmith unveils results for neuromuscular disease treatment by Lee Han-soo 2019-08-02 17:52
‘MSD Korea playing tricks to maintain monitoring on salespersons’ by Kim Yun-mi 2019-08-02 15:48
Conflict erupts between employees of Takeda, Shire during merger by Kim Yun-mi 2019-08-02 14:23
Sillajen likely to scrap global P3 trials for Pexa-Vec by Lee Han-soo 2019-08-02 10:29
KAIST-Hanyang University team presents new anticancer principle by Lee Han-soo 2019-08-01 17:30
Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia by Lee Han-soo 2019-08-01 13:36
New weight loss drug Qsymia wins local approval by Lee Hye-seon 2019-08-01 10:57
‘Hanmi’s Carnitil improves cognitive function in patients’ by Lee Han-soo 2019-07-31 17:05
Hanall marks record sales in Q2 by Lee Han-soo 2019-07-31 17:00
Novartis fails to expand heart failure drug Entresto’s indication by Kim Yun-mi 2019-07-31 14:26
Hanmi marks ₩270.4 billion in Q2 sales by Lee Han-soo 2019-07-30 17:26
Kolmar Korea boosts beauty, health biz through acquisitions by Park Gi-taek 2019-07-30 14:43
GC’s Chinese partner applies for Hunter syndrome drug’s sales approval by Lee Han-soo 2019-07-30 10:49
‘FDA likely to OK 11 blockbuster candidates in August’ by Kim Yun-mi 2019-07-29 16:55
Top-30 makers produce more than half of drugs by Lee Hye-seon 2019-07-29 16:38
Takeda’s Zejula poised to change local ovarian cancer treatment market by Kim Yun-mi 2019-07-29 12:04
Back to Top